GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » EPS without NRI

Aroa Biosurgery (ASX:ARX) EPS without NRI : A$-0.02 (TTM As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery EPS without NRI?

Aroa Biosurgery's earnings per share without non-recurring items for the six months ended in Sep. 2023 was A$-0.02. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2023 was A$-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Aroa Biosurgery's EPS without NRI or its related term are showing as below:

ASX:ARX's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9.65
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Aroa Biosurgery's EPS (Diluted) for the six months ended in Sep. 2023 was A$-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was A$-0.02.

Aroa Biosurgery's EPS (Basic) for the six months ended in Sep. 2023 was A$-0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was A$-0.02.


Aroa Biosurgery EPS without NRI Historical Data

The historical data trend for Aroa Biosurgery's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery EPS without NRI Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23
EPS without NRI
- -0.06 -0.02 -

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EPS without NRI Get a 7-Day Free Trial -0.02 -0.01 - -0.01 -0.02

Competitive Comparison of Aroa Biosurgery's EPS without NRI

For the Medical Devices subindustry, Aroa Biosurgery's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aroa Biosurgery's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Aroa Biosurgery's PE Ratio without NRI falls into.



Aroa Biosurgery EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aroa Biosurgery  (ASX:ARX) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Aroa Biosurgery EPS without NRI Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines